CEO of PharmaKure Receives Pioneer Award

ASIANS in Tech announces Pioneer Awards for those making the most Innovation and Impact in the UK

Dr Khan, CEO of PharmaKure attended the 10th Asians in Tech event which was an inspiring event. It ranged from young start-up entrepreneurs eager to pitch to investors to seasoned billionaires giving advice on the power of resilience and what to avoid in business. The evening was filled with phenomenal demo exhibitions, an inspiring keynote speaker, fantastic elevator pitches, and the prestigious awards celebrating Top 100 ASIAN Starts in UK Tech, ASIAN Tech Pioneers & Tech Showcase.

“Your achievements are incredibly well-deserved. Keep pushing boundaries and doing great things. We champion diversity and celebrate the innovative spirit you bring to the tech industry” explained the Asians in Tech Team.

Dr. Farid Khan, co-founder of PharmaKure Ltd, was awarded in the category of Asian Tech Pioneers. As they put it ‘Dr. Khan is a leading biotech entrepreneur, who has founded companies focused on Alzheimer’s Drug and Diagnostic development to AI based diagnosis in cancer and diabetes to manufacturing of biologics/cultivating meat using plant based recombinant technology.’

‘Dr. Khan is the CEO of PharmaKure, a clinical stage pharmaceutical company developing precision medicines for Alzheimer’s Disease announced that the UK Medicines and Healthcare Regulatory Agency (MHRA) has granted Clinical Trial Authorisation (CTA) for it to commence a study to evaluate safety and tolerability of its treatment for the treatment of mild cognitive impairment (MCI). Recently it has developed blood-based biomarkers for diagnosing Alzheimer’s 10-15 years before symptoms occur.’

The event was inspirational, with the greatest respect to the tireless – Lopa Patel MBE, deputy Chair, Ramesh Vala CBE and trustees: Sareeta Vala, Vimla Appadoo and Francesca Jus-Burke and the sponsors.

Editors’ notes

About Alzheimer’s Disease – Alzheimer’s disease is a fatal illness that causes progressive decline in memory and other aspects of cognition. Dementia due to Alzheimer’s is the most common form of dementia, accounting for 60 to 80 percent of all cases. Every three seconds someone in the world develops dementia. 850,000 people (UK) and 44 million people (worldwide) are currently suffering from Alzheimer’s or dementia related illnesses. In 2020, the total cost of care for people in the UK was £34.7 billion. Globally, the cost was $360 billion and by 2050 it could reach $1 trillion (source Alzheimer’s Research UK), unless we find a way to slow the disease.

About PharmaKure – PharmaKure is a UK based pharmaceutical company, spun out from the University of Manchester. The company is actively researching, developing, commercialising and repositioning repurposed drugs for the treatment of Alzheimer’s, Parkinson’s and other neurodegenerative diseases, as well as developing the ALZmetrixTM diagnostic.

For more information, contact [email protected], or see Pharmakure’s website

Company Contacts

CEO: Dr Farid Khan – [email protected]
CCO: Dr Naz Bashir – [email protected]